Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 322

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma

Open access
Pistollato, Francesca, Abbadi, Sara, Rampazzo, Elena, Persano, Luca, Della Puppa, Alessandro, Frasson, Chiara, Sarto, Eva, Scienza, Renato, D'avella, Domenico, Basso, Giuseppe·2010·Stem Cells

Abstract

Glioblastoma multiforme (GBM) are highly proliferative tumors currently treated by surgical removal, followed by radiotherapy and chemotherapy, which are counteracted by intratumoral hypoxia. Here we exploited image guided surgery to sample multiple intratumoral areas to define potential cellular heterogeneity in correlation to the oxygen tension gradient within the GBM mass. Our results indicate that more immature cells are localized in the inner core and in the intermediate layer of the tumor mass, whereas more committed cells, expressing glial fibrillary acidic protein and β-III-tubulin, are distributed along the peripheral and neo-vascularized area, where Smad1/5/8 and Stat3 result to be activated. Moreover, GBM stem cells, identified with the stem cell marker CD133, express high level of DNA repair protein O6-methylguanine-DNA-methyltransferase (MGMT) known to be involved in chemotherapy resistance and highly expressed in the inner core of the tumor mass. Importantly, these cells and, particularly, CD133+ cells result to be resistant to temozolomide (TMZ), the most used oral alkylating agent for the treatment of GBM, which specifically causes apoptosis only in GBM cells derived from the peripheral layer of the tumor mass. These results indicate a correlation between the intratumoral hypoxic gradient, the tumor cell phenotype, and the tumor resistance to chemotherapy leading to a novel concentric model of tumor stem cell niche, which may be useful to define the real localization of the chemoresistant GBM tumor cells in order to design more effective treatment strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/stem.415

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 40

  1. Louis, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, 114, 97, 10.1007/s00401-007-0243-4 · DOI · Paper page
  2. Altaner, 2008, Glioblastoma and stem cells, Neoplasma, 55, 369
  3. Higa, 2009, Biological mechanisms of bevacizumab-associated adverse events, Expert Rev Anticancer Ther, 9, 999, 10.1586/era.09.68 · DOI
  4. Sanchez-Martin, 2008, Brain tumour stem cells: Implications for cancer therapy and regenerative medicine, Curr Stem Cell Res Ther, 3, 197, 10.2174/157488808785740370 · doi:10.2174/157488808785740370
  5. Beier, 2008, Temozolomide preferentially depletes cancer stem cells in glioblastoma, Cancer Res, 68, 5706, 10.1158/0008-5472.CAN-07-6878 · DOI · Paper page
  6. Liu, 2006, Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma, Mol Cancer, 5, 67, 10.1186/1476-4598-5-67 · DOI · Paper page
  7. Murat, 2008, Stem cell-related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma, J Clin Oncol, 26, 3015, 10.1200/JCO.2007.15.7164 · DOI · Paper page
  8. Chinot, 2007, Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide, J Clin Oncol, 25, 1470, 10.1200/JCO.2006.07.4807 · DOI · Paper page
  9. Hegi, 2005, MGMT gene silencing and benefit from temozolomide in glioblastoma, N Engl J Med, 352, 997, 10.1056/NEJMoa043331 · DOI · Paper page
  10. Cao, 2009, The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas, Neurosurgery, 65, 866, 10.1227/01.NEU.0000357325.90347.A1 · doi:10.1227/01.neu.0000357325.90347.a1
  11. Azuma, 2003, Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: Pimonidazole and involucrin, Clin Cancer Res, 9, 4944
  12. Helczynska, 2003, Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ, Cancer Res, 63, 1441
  13. Smith, 2005, Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL−/− renal cancer, Cancer Res, 65, 5221, 10.1158/0008-5472.CAN-05-0169 · DOI · Paper page
  14. Amberger-Murphy, 2009, Hypoxia helps glioma to fight therapy, Curr Cancer Drug Targets, 9, 381, 10.2174/156800909788166637 · DOI
  15. Pistollato, 2009, Hypoxia and HIF1alpha repress the differentiative effects of BMPs in high-grade glioma, Stem Cell., 27, 7, 10.1634/stemcells.2008-0402 · DOI
  16. Pistollato, 2009, Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells, Plos One, 4, e6206, 10.1371/journal.pone.0006206 · DOI
  17. Piccirillo, 2009, Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution, Oncogene, 28, 1807, 10.1038/onc.2009.27 · DOI · Paper page
  18. Hegi, 2008, Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity, J Clin Oncol, 26, 4189, 10.1200/JCO.2007.11.5964 · DOI · Paper page
  19. Schwartz, 2003, Isolation and characterization of neural progenitor cells from post-mortem human cortex, J Neurosci Res, 74, 838, 10.1002/jnr.10854 · DOI · Paper page
  20. Pistollato, 2007, Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes, Mol Cell Neurosci, 35, 424, 10.1016/j.mcn.2007.04.003 · DOI · Paper page
  21. Viola, 2006, Induction of apoptosis by photoexcited tetracyclic compounds derivatives of benzo[b]thiophenes and pyridines, J Photochem Photobiol B, 82, 105, 10.1016/j.jphotobiol.2005.09.004 · DOI
  22. Marin-Hernandez, 2009, HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms, Mini Rev Med Chem, 9, 1084, 10.2174/138955709788922610 · DOI · Paper page
  23. Liao, 2009, Expression of transmembrane carbonic anhydrases, Caix And CAXII, in human development, BMC Dev Biol, 9, 22, 10.1186/1471-213X-9-22 · DOI
  24. Rempel, 1998, SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas, J Neuropathol Exp Neurol, 57, 1112, 10.1097/00005072-199812000-00002 · DOI
  25. Perrin, 2009, Glial vascular endothelial growth factor overexpression in rat brainstem under tolerable hypoxia: Evidence for a central chemosensitivity, J Neurosci Res, 87, 79, 10.1002/jnr.21837 · DOI
  26. Nakashima, 1999, Astrocyte differentiation mediated by LIF in cooperation with BMP2, FEBS Lett, 457, 43, 10.1016/S0014-5793(99)00997-7 · DOI
  27. Galli, 2004, Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma, Cancer Res, 64, 7011, 10.1158/0008-5472.CAN-04-1364 · DOI · Paper page
  28. Hemmati, 2003, Cancerous stem cells can arise from pediatric brain tumors, Proc Natl Acad Sci USA, 100, 15178, 10.1073/pnas.2036535100 · DOI · Paper page
  29. Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167 · DOI · Paper page
  30. Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128 · DOI · Paper page
  31. Yuan, 2004, Isolation of cancer stem cells from adult glioblastoma multiforme, Oncogene, 23, 9392, 10.1038/sj.onc.1208311 · DOI · Paper page
  32. Fu, 2009, Glioblastoma stem cells resistant to temozolomide-induced autophagy, Chin Med J (Engl), 122, 1255
  33. McCord, 2009, CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines, Clin Cancer Res, 15, 5145, 10.1158/1078-0432.CCR-09-0263 · DOI · Paper page
  34. Panchision, 2007, Optimized flow cytometric analysis of central nervous system tissue reveals novel functional relationships among cells expressing CD133, CD15, and CD24, Stem Cells, 25, 1560, 10.1634/stemcells.2006-0260 · DOI
  35. Schold, 2004, O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas, Neuro Oncol, 6, 28, 10.1215/S115285170300019X · doi:10.1215/s115285170300019x
  36. Spiro, 1999, O6-benzylguanine: A clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair, Cancer Res, 59, 2402
  37. Calabrese, 2007, A perivascular niche for brain tumor stem cells, Cancer Cell, 11, 69, 10.1016/j.ccr.2006.11.020 · DOI · Paper page
  38. Gilbertson, 2007, Making a tumour's bed: Glioblastoma stem cells and the vascular niche, Nat Rev Cancer, 7, 733, 10.1038/nrc2246 · DOI · Paper page
  39. Heddleston, 2, Hypoxia inducible factors in cancer stem cells, Br J Cancer, 102, 789, 10.1038/sj.bjc.6605551 · DOI · Paper page
  40. Panchision, 2009, The role of oxygen in regulating neural stem cells in development and disease, J Cell Physiol, 220, 562, 10.1002/jcp.21812 · DOI · Paper page

Cited by

See all 322

Metadata

Authors
Pistollato, F., Abbadi, S., Rampazzo, E., Persano, L., Della Puppa, A., Frasson, C., Sarto, E., Scienza, R., D'avella, D., & Basso, G.
Venue
Stem Cells
Published
2010-03-22
Volume
28
Issue
5
Pages
851-862
ISSN
  • 1066-5099 (ISSN-L)
  • 1549-4918
OpenAlex
W2083081144
Cited by
322
References
5
FWCI
7.90
Type
journal article
Language
en
Open access
bronze
Funders
Italian Association for the Fight against Neuroblastoma (Pensiero Project) and the Italian Association AIRC

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.